Stay updated with breaking news from Multiple System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON and ATLANTA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage phar...
Jane Frances Holmes, age 72, passed away peacefully on Nov. 2, 2023, at the Pheasant Wood Center in Peterborough, surrounded by the support and love of her family and friends.
– ATH434-201 is a randomized, double-blind, placebo-controlled study in early-stage MSA – – Lead clinical development program enrolled 77 participants...
– ATH434-201 is a randomized, double-blind, placebo-controlled study in early-stage MSA – – Lead clinical development program enrolled 77 participants globally – MELBOURNE, Australia...
Inhibikase Therapeutics, Inc. (IKT) announced that risvodetinib has been granted Orphan Drug Designation by the FDA for the treatment of Multiple System Atrophy.